
Prader-Willi Syndrome Market Poised for Growth Through 2036
With approximately 26,000 diagnosed cases across seven major markets in 2025, the Prader-Willi syndrome landscape is bracing for a shift. Driven by improved diagnostic precision and a wave of emerging therapies, the market is projected to expand significantly as companies move beyond traditional growth hormone treatments to target hyperphagia.
























